Amazon launches GLP-1 weight loss drug program through its subsidiary One Medical

Glonghui April 22｜Amazon will launch a program through its primary healthcare unit, One Medical, to offer GLP-1 therapy. The company stated on Tuesday that, compared to one-off weight management solutions offered by other providers, this new program aims to provide ongoing medical supervision, enabling clinicians to monitor progress, adjust treatment plans, and address related health issues. Through this program, customers can access Novo Nordisk’s Wegovy and Eli Lilly’s Foundayo GLP-1 weight loss tablets, with insurance-covered prices starting at $25 per month and self-pay options at $149 per month. The $149 starting dose self-pay price is comparable to prices offered by companies such as Hims & Hers Health, Walgreens, and Weight Watchers.